Gumapac, Erlinda B.
HRN: 27-64-41 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2025
CEFTAZIDIME 1GM (VIAL)
08/18/2025
08/24/2025
IV
1g
Q8h
CAPMR
Checking Initial Appropriateness
08/18/2025
AZITHROMYCIN 500MG TABLET (TAB)
08/18/2025
08/22/2025
PO
500mg
Od
CAPMR
Checking Initial Appropriateness